Index
1 Market Overview of Monogenetic Disorders Testing
1.1 Monogenetic Disorders Testing Market Overview
1.1.1 Monogenetic Disorders Testing Product Scope
1.1.2 Monogenetic Disorders Testing Market Status and Outlook
1.2 Global Monogenetic Disorders Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Monogenetic Disorders Testing Market Size by Region (2018-2029)
1.4 Global Monogenetic Disorders Testing Historic Market Size by Region (2018-2023)
1.5 Global Monogenetic Disorders Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Monogenetic Disorders Testing Market Size (2018-2029)
1.6.1 North America Monogenetic Disorders Testing Market Size (2018-2029)
1.6.2 Europe Monogenetic Disorders Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Monogenetic Disorders Testing Market Size (2018-2029)
1.6.4 Latin America Monogenetic Disorders Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Monogenetic Disorders Testing Market Size (2018-2029)
2 Monogenetic Disorders Testing Market by Type
2.1 Introduction
2.1.1 Carrier Testing
2.1.2 Diagnostic Testing
2.1.3 New-Born Screening
2.1.4 Predictive & Pre-Symptomatic Testing
2.1.5 Prenatal Testing
2.1.6 Others
2.2 Global Monogenetic Disorders Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Monogenetic Disorders Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Monogenetic Disorders Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Monogenetic Disorders Testing Revenue Breakdown by Type (2018-2029)
3 Monogenetic Disorders Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialized Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Monogenetic Disorders Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Monogenetic Disorders Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Monogenetic Disorders Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Monogenetic Disorders Testing Revenue Breakdown by Application (2018-2029)
4 Monogenetic Disorders Testing Competition Analysis by Players
4.1 Global Monogenetic Disorders Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2022)
4.3 Date of Key Players Enter into Monogenetic Disorders Testing Market
4.4 Global Top Players Monogenetic Disorders Testing Headquarters and Area Served
4.5 Key Players Monogenetic Disorders Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Monogenetic Disorders Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Celera Group
5.1.1 Celera Group Profile
5.1.2 Celera Group Main Business
5.1.3 Celera Group Monogenetic Disorders Testing Products, Services and Solutions
5.1.4 Celera Group Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Celera Group Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Monogenetic Disorders Testing Products, Services and Solutions
5.2.4 Abbott Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.3.5 ELITech Group Recent Developments
5.4 ELITech Group
5.4.1 ELITech Group Profile
5.4.2 ELITech Group Main Business
5.4.3 ELITech Group Monogenetic Disorders Testing Products, Services and Solutions
5.4.4 ELITech Group Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.4.5 ELITech Group Recent Developments
5.5 Quest
5.5.1 Quest Profile
5.5.2 Quest Main Business
5.5.3 Quest Monogenetic Disorders Testing Products, Services and Solutions
5.5.4 Quest Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Quest Recent Developments
5.6 AutoGenomics
5.6.1 AutoGenomics Profile
5.6.2 AutoGenomics Main Business
5.6.3 AutoGenomics Monogenetic Disorders Testing Products, Services and Solutions
5.6.4 AutoGenomics Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.6.5 AutoGenomics Recent Developments
5.7 PerkinElmer
5.7.1 PerkinElmer Profile
5.7.2 PerkinElmer Main Business
5.7.3 PerkinElmer Monogenetic Disorders Testing Products, Services and Solutions
5.7.4 PerkinElmer Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.7.5 PerkinElmer Recent Developments
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business
5.8.3 Roche Monogenetic Disorders Testing Products, Services and Solutions
5.8.4 Roche Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Recent Developments
5.9 Bio-Rad
5.9.1 Bio-Rad Profile
5.9.2 Bio-Rad Main Business
5.9.3 Bio-Rad Monogenetic Disorders Testing Products, Services and Solutions
5.9.4 Bio-Rad Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Bio-Rad Recent Developments
5.10 Transgenomic
5.10.1 Transgenomic Profile
5.10.2 Transgenomic Main Business
5.10.3 Transgenomic Monogenetic Disorders Testing Products, Services and Solutions
5.10.4 Transgenomic Monogenetic Disorders Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Transgenomic Recent Developments
6 North America
6.1 North America Monogenetic Disorders Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Monogenetic Disorders Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monogenetic Disorders Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monogenetic Disorders Testing Market Dynamics
11.1 Monogenetic Disorders Testing Industry Trends
11.2 Monogenetic Disorders Testing Market Drivers
11.3 Monogenetic Disorders Testing Market Challenges
11.4 Monogenetic Disorders Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List